| 1 |
Zhang J, Qiao W, Luo Y. Mitochondrial quality control proteases and their modulation for cancer therapy. Med Res Rev 2023;43:399-436. [PMID: 36208112 DOI: 10.1002/med.21929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Feng L, Li Z, Xiong Y, Yan T, Fu C, Zeng Q, Wang H. HtrA2 Independently Predicts Poor Prognosis and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma. J Oncol 2023;2023:4067418. [PMID: 36704205 DOI: 10.1155/2023/4067418] [Reference Citation Analysis]
|
| 3 |
Wu L, Li X, Chen X, Wu F, Sun G, Cheng Y, Tang W, Zhang W, Lv C. mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer. J Clin Lab Anal 2021;:e24054. [PMID: 34708890 DOI: 10.1002/jcla.24054] [Reference Citation Analysis]
|
| 4 |
Wu L, Li X, Li Z, Cheng Y, Wu F, Lv C, Zhang W, Tang W. HtrA serine proteases in cancers: A target of interest for cancer therapy. Biomed Pharmacother 2021;139:111603. [PMID: 34243596 DOI: 10.1016/j.biopha.2021.111603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Gomez-Fabra Gala M, Vögtle FN. Mitochondrial proteases in human diseases. FEBS Lett 2021;595:1205-22. [PMID: 33453058 DOI: 10.1002/1873-3468.14039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 6 |
Abdel Ghafar MT, Gharib F, Al-ashmawy GM, Mariah RA. Serum high-temperature-required protein A2: A potential biomarker for the diagnosis of breast cancer. Gene Reports 2020;20:100706. [DOI: 10.1016/j.genrep.2020.100706] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 7 |
Zurawa-Janicka D, Kobiela J, Slebioda T, Peksa R, Stanislawowski M, Wierzbicki PM, Wenta T, Lipinska B, Kmiec Z, Biernat W, Lachinski AJ, Sledzinski Z. Expression of HTRA Genes and Its Association with Microsatellite Instability and Survival of Patients with Colorectal Cancer. Int J Mol Sci 2020;21:E3947. [PMID: 32486357 DOI: 10.3390/ijms21113947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Lv Q, Yu S, Quan F, He C, Chen X. Thermosensitive Polypeptide Hydrogels Co‐Loaded with Two Anti‐Tumor Agents to Reduce Multi‐Drug Resistance and Enhance Local Tumor Treatment. Adv Therap 2020;3:1900165. [DOI: 10.1002/adtp.201900165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 9 |
Wang H, Jiang F, Hao F, Ju R. The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma. Medicine (Baltimore) 2018;97:e0128. [PMID: 29620624 DOI: 10.1097/MD.0000000000010128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 10 |
Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K. Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1058-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 11 |
Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, Ciarkowski J, Lipinska B. Structural insights into the activation mechanisms of human HtrA serine proteases. Arch Biochem Biophys 2017;621:6-23. [PMID: 28396256 DOI: 10.1016/j.abb.2017.04.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
|
